Literature DB >> 24115387

Targeted deep resequencing identifies MID2 mutation for X-linked intellectual disability with varied disease severity in a large kindred from India.

Thenral S Geetha1, Kulandaimanuvel Antony Michealraj, Madhulika Kabra, Gurjit Kaur, Ramesh C Juyal, B K Thelma.   

Abstract

We report a novel missense mutation (c.1040G>A, p.Arg347Gln) in MID2, which encodes ubiquitin ligase E3, as the likely cause of X-linked mental retardation in a large kindred. The mutation was observed in all affected and obligate carriers but not in any unaffected males of the family or in population controls (n = 200). When transiently expressed in HEK293T cell line, the mutation was found to abolish the function of the COS domain in the protein. The GFP-tagged mutant protein accumulated in the cytoplasm instead of binding to the cytoskeleton resulting in its altered subcellular localization. Screening of coding exons of this gene in additional 480 unrelated individuals with idiopathic intellectual disability identified another novel variation p.Asn343Ser. This study highlights the growing role of the ubiquitin pathway in intellectual disability and also, the difference in MID2 determined phenotype observed in this study compared with that of its paralogue MID1 reported in literature.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Keywords:  MID2; X-linked intellectual disability; linkage analysis; targeted resequencing

Mesh:

Substances:

Year:  2013        PMID: 24115387     DOI: 10.1002/humu.22453

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  19 in total

1.  Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features.

Authors:  Teresa Santiago-Sim; Lindsay C Burrage; Frédéric Ebstein; Mari J Tokita; Marcus Miller; Weimin Bi; Alicia A Braxton; Jill A Rosenfeld; Maher Shahrour; Andrea Lehmann; Benjamin Cogné; Sébastien Küry; Thomas Besnard; Bertrand Isidor; Stéphane Bézieau; Isabelle Hazart; Honey Nagakura; LaDonna L Immken; Rebecca O Littlejohn; Elizabeth Roeder; Bulent Kara; Katia Hardies; Sarah Weckhuysen; Patrick May; Johannes R Lemke; Orly Elpeleg; Bassam Abu-Libdeh; Kiely N James; Jennifer L Silhavy; Mahmoud Y Issa; Maha S Zaki; Joseph G Gleeson; John R Seavitt; Mary E Dickinson; M Cecilia Ljungberg; Sara Wells; Sara J Johnson; Lydia Teboul; Christine M Eng; Yaping Yang; Peter-Michael Kloetzel; Jason D Heaney; Magdalena A Walkiewicz
Journal:  Am J Hum Genet       Date:  2017-03-23       Impact factor: 11.025

2.  Activity-based probe profiling of RNF12 E3 ubiquitin ligase function in Tonne-Kalscheuer syndrome.

Authors:  Francisco Bustos; Sunil Mathur; Carmen Espejo-Serrano; Rachel Toth; C James Hastie; Satpal Virdee; Greg M Findlay
Journal:  Life Sci Alliance       Date:  2022-06-28

Review 3.  The MID1 gene product in physiology and disease.

Authors:  Rossella Baldini; Martina Mascaro; Germana Meroni
Journal:  Gene       Date:  2020-04-10       Impact factor: 3.688

4.  The X-Linked-Intellectual-Disability-Associated Ubiquitin Ligase Mid2 Interacts with Astrin and Regulates Astrin Levels to Promote Cell Division.

Authors:  Ankur A Gholkar; Silvia Senese; Yu-Chen Lo; Edmundo Vides; Ely Contreras; Emmanuelle Hodara; Joseph Capri; Julian P Whitelegge; Jorge Z Torres
Journal:  Cell Rep       Date:  2015-12-31       Impact factor: 9.423

5.  Truncation of the E3 ubiquitin ligase component FBXO31 causes non-syndromic autosomal recessive intellectual disability in a Pakistani family.

Authors:  Asif Mir; Kumudesh Sritharan; Kirti Mittal; Nasim Vasli; Carolina Araujo; Talal Jamil; Muhammad Arshad Rafiq; Zubair Anwar; Anna Mikhailov; Sobiah Rauf; Huda Mahmood; Abdul Shakoor; Sabir Ali; Joyce So; Farooq Naeem; Muhammad Ayub; John B Vincent
Journal:  Hum Genet       Date:  2014-03-13       Impact factor: 4.132

6.  Phenotypic spectrum associated with SPECC1L pathogenic variants: new families and critical review of the nosology of Teebi, Opitz GBBB, and Baraitser-Winter syndromes.

Authors:  Elizabeth J Bhoj; Damien Haye; Annick Toutain; Dominique Bonneau; Irene Kibæk Nielsen; Ida Bay Lund; Pauline Bogaard; Stine Leenskjold; Kadri Karaer; Katherine T Wild; Katheryn L Grand; Mirena C Astiazaran; Luis A Gonzalez-Nieto; Ana Carvalho; Daphné Lehalle; Shivarajan M Amudhavalli; Elena Repnikova; Carol Saunders; Isabelle Thiffault; Irfan Saadi; Dong Li; Hakon Hakonarson; Yoann Vial; Elaine Zackai; Patrick Callier; Séverine Drunat; Alain Verloes
Journal:  Eur J Med Genet       Date:  2018-11-22       Impact factor: 2.465

7.  Medical genetics and genomic medicine in India: current status and opportunities ahead.

Authors:  Shagun Aggarwal; Shubha R Phadke
Journal:  Mol Genet Genomic Med       Date:  2015-05       Impact factor: 2.183

8.  Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome.

Authors:  Bijun Li; Tianhong Zhou; Yi Zou
Journal:  Mol Genet Genomic Med       Date:  2015-12-12       Impact factor: 2.183

Review 9.  Neuronal Cytoskeleton in Intellectual Disability: From Systems Biology and Modeling to Therapeutic Opportunities.

Authors:  Carla Liaci; Mattia Camera; Giovanni Caslini; Simona Rando; Salvatore Contino; Valentino Romano; Giorgio R Merlo
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

10.  X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes.

Authors:  H Hu; S A Haas; J Chelly; H Van Esch; M Raynaud; A P M de Brouwer; S Weinert; G Froyen; S G M Frints; F Laumonnier; T Zemojtel; M I Love; H Richard; A-K Emde; M Bienek; C Jensen; M Hambrock; U Fischer; C Langnick; M Feldkamp; W Wissink-Lindhout; N Lebrun; L Castelnau; J Rucci; R Montjean; O Dorseuil; P Billuart; T Stuhlmann; M Shaw; M A Corbett; A Gardner; S Willis-Owen; C Tan; K L Friend; S Belet; K E P van Roozendaal; M Jimenez-Pocquet; M-P Moizard; N Ronce; R Sun; S O'Keeffe; R Chenna; A van Bömmel; J Göke; A Hackett; M Field; L Christie; J Boyle; E Haan; J Nelson; G Turner; G Baynam; G Gillessen-Kaesbach; U Müller; D Steinberger; B Budny; M Badura-Stronka; A Latos-Bieleńska; L B Ousager; P Wieacker; G Rodríguez Criado; M-L Bondeson; G Annerén; A Dufke; M Cohen; L Van Maldergem; C Vincent-Delorme; B Echenne; B Simon-Bouy; T Kleefstra; M Willemsen; J-P Fryns; K Devriendt; R Ullmann; M Vingron; K Wrogemann; T F Wienker; A Tzschach; H van Bokhoven; J Gecz; T J Jentsch; W Chen; H-H Ropers; V M Kalscheuer
Journal:  Mol Psychiatry       Date:  2015-02-03       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.